Abstract
Background
We hypothesized that since asthma is a chronic inflammatory disease, it could lead to the early development of atherosclerosis in childhood-onset asthma. The aim of this study was to investigate arterial stiffness, distensibility, and strain of different peripheral arteries, the parameters of which can be used to detect atherosclerosis in asthmatic children.
Material/Methods
We studied 22 pediatric patients with asthma and 18 healthy children. Fasting blood glucose and cholesterol levels were evaluated to exclude children with diabetes and hyperlipidemia, which are risk factors for atherosclerosis. Renal, carotid, and brachial arteries diameters were measured. Using the measured data, stiffness, distensibility, and strain of the arteries of all children were calculated.
Results
Pulse pressure, systolic and diastolic blood pressure, heart rate, cholesterols, and glucose levels of the obese individuals were similar to the controls. In carotid arteries there were no statistical differences regarding stiffness, distensibility, and strain. According to multiple ANCOVA analysis, distensibility and strain of right and left brachial arteries and right renal artery were higher, whereas right renal artery stiffness was lower in asthmatic children than in controls. Approximately one-fifth of the change in the left and right brachial arteries and right renal artery distensibility and strain and a small portion of the change in the right renal artery stiffness were associated with asthma. In contrast, left renal artery distensibility, strain, and stiffness were not associated with asthma.
Conclusions
Peripheral arteries had higher distensibility and strain, and lower stiffness in asthmatic children than in controls.
MeSH Keywords: Arteries, Asthma, Child, Vascular Stiffness
Background
Asthma is a chronic inflammatory disorder of the airways, associated with airway obstruction and hyper-responsiveness. It is characterized by recurrent episodes of wheezing, breathlessness, and coughing [1]. Asthma is a multifactorial disease and interactions between genetic and environmental factors play roles in its pathogenesis. A meta-analysis suggested that IL13–1112C/T and +2044A/G polymorphisms were associated with increased pediatric asthma risk [2]. Some studies revealed that the genetic pathogenic variants may be responsible for the reduced immunity, reporting low cellular eosinophilic response and relatively low expression of IL-12, IFN-γ, and TNF-α in children in remission. It has also been suggested that the consequent prolonged psychological stress can disturb recovery from asthma and may contribute to the development of chronic asthma in children [3]. Atherosclerosis and asthma are both chronic inflammatory disorders. Asthma is not only associated with multiple markers of chronic systemic inflammation, but also with increased risk of atherogenesis [4]. Chronic inflammation via common inflammatory pathways [5,6] is associated with atherosclerosis [7], endothelial dysfunction [8], arterial stiffness [9], and subsequent adverse cardiovascular events [10]. Some studies reported that peripheral arterial stiffness is related to atherosclerosis and adverse cardiovascular outcomes [11,12]. Inflammation causes impairment of endothelial cell function, and accelerates atherosclerosis [8].
Elevated arterial stiffness is associated with myocardial infarction, heart failure, renal disease, stroke, and increased total mortality rates in adults. Thus, elevated arterial stiffness is considered as a marker of subclinical atherosclerosis [13]. Arterial stiffness is a mechanical property related to vascular impedance and the afterload presented to the left ventricle. Reduction in arterial distensibility leads to increased pulse pressure, and impedance of arterial flow and pulsatile cardiac workload [14].
The present case-control study was designed to measure arterial stiffness, distensibility, and strain from different peripheral arteries in asthmatic children and to compare these to healthy control subjects to determine the impact of asthma on cardiovascular outcome.
Material and Methods
We studied 22 pediatric patients (14 male and 8 female) selected randomly from those with bronchial asthma, and 18 healthy subjects. The individuals who met the criteria for bronchial asthma (1) diagnosis were included in the study. Exclusion criteria were: comorbid diseases, such as upper or lower respiratory infection, allergic rhinitis, gastroesophageal reflux, or obesity; chronic cardiovascular or pulmonary diseases; acute asthma attack during the last 4 weeks; a history of chronic inflammation/rheumatological disorders, diabetes, hypertension, or hypercholesterolemia; and with autoimmune diseases and smoking exposure. The control group consisted of 18 healthy children chosen from the population referred to the pediatric cardiology out-patient clinics. After approval of the Ethics Committee of the institution, informed consents signed by the parents were obtained.
Present and past history, symptoms, and signs of all patients were recorded by the same physician. Heart rate (HR) and blood pressure (BP) of all children were recorded. After 12-hour fasting, the blood samples of the patients were measured for glucose, total cholesterol, triglyceride, high-density lipoprotein (HDL), and low-density lipoprotein (LDL).
All asthmatic patients involved in this study were receiving inhaled corticosteroids treatment for various periods of time and in various doses
BP measurements were performed after 15 minutes of rest; the right brachial artery pressure was measured by sphygmomanometer with an appropriate cuff. Both systolic (Ps) and diastolic blood pressure (Pd) were measured, and after 3 measurements, the mean value was recorded. Pulse pressure (PP) was calculated as PP = Ps – Pd.
Distensibility, strain, and stiffness were calculated as follows:
[14].
[14].
[15].
Carotid arteries were measured from 1 cm proximal to the bifurcation level, brachial arteries were measured in the middle of the plane arm, and renal arteries were measured 1 cm from the origin of the abdominal aorta. Every measurement was performed at the widest systolic and diastolic arterial diameter. All measurements were performed by the same radiologist. Arterial measurements were made by use of a GE Logic 7S Duplex ultrasonography device with probe at a frequency of 3.1–10 MHz for B scan.
Statistical analyses
The statistical analyses were performed using SPSS. Independent t test and ANCOVA test were used to analyze the data. The arithmetic average of radiological measurements of asthmatic and healthy children was compared with the independent t test. The important parameters according to the independent t test were evaluated by using multiple ANCOVA analysis. The mean age of controls (mean age, 9.09 years) was higher than asthmatic children (mean age, 12.15 years). Therefore, age variability was taken as covariate variable in multiple ANCOVA analysis. ANCOVA analysis was performed in asthma and control groups as fixed factors and age variables as covariate variable. Statistical significance was defined as p<0.05.
Results
The study group consisted of 22 children with asthma. There was no difference between the groups in terms of Ps, Pd, pulse pressure, (HR), fasting glucose, or cholesterols. The mean age was higher in the control group than in asthmatic patients (Table 1).
Table 1.
Asthma patients 22 (M/F=14/8) | Control group 18 (M/F=10/8) | p value | |
---|---|---|---|
Age (year) | 9.09±3.19 | 12.15±3.71 | 0.009* |
Systolic BP (mmHg) | 106.742±6.450 | 100.796±7.666 | 0.115 |
Diastolic BP (mmHg) | 65.136±6.636 | 60.481±5.061 | 0.157 |
Pulse pressure | 41.606±5.831 | 38.315±6.908 | 0.110 |
Heart rate (bpm) | 84.68±14.93 | 86.42±10.87 | 0.537 |
Glucose (mg/dL) | 89.19±7.19 | 88.45±9.13 | 0.650 |
Total cholesterol (mg/dl) | 152.5±32.6 | 147.5±24.6 | 0.125 |
LDL cholesterol (mg/dl) | 82.16±11.8 | 75.1±15.1 | 0.135 |
HDL cholesterol (mg/dl) | 53.6±12.3 | 50.5±12 | 0.128 |
Triglyceride (mg/dL) | 84.88±32 | 80±25 | 0.145 |
Statistically significant (p<0.05);
BP – blood pressure; LDL – low-density lipoprotein; HDL – high-density lipoprotein.
We evaluated stiffness, distensibility, and strain from carotid, renal, and brachial arteries. Carotid arteries measurements showed statistically significant differences regarding stiffness, distensibility and strain (Table 2).
Table 2.
Radiological measurements | Groups | n | Mean | S.D. | t | Sig. |
---|---|---|---|---|---|---|
Arterial CCA R-distensibilty | Asthma | 22 | 17.426 | 7.685 | −.413 | .682 |
Control | 18 | 18.508 | 8.884 | |||
Arterial CCA R-strain | Asthma | 22 | .207 | .082 | −1.017 | .316 |
Control | 18 | .234 | .085 | |||
Arterial CCA R-stiffness | Asthma | 22 | 2.775 | 1.206 | 1.788 | .082 |
Control | 18 | 2.190 | .755 | |||
Arterial CCA L-distensibility | Asthma | 22 | 15.666 | 6.502 | 1.638 | .110 |
Control | 18 | 12.685 | 4.594 | |||
Arterial CCA L-stiffness | Asthma | 22 | 3.004 | 1.234 | −.453 | .653 |
Control | 18 | 3.218 | 1.749 | |||
Arterial CCA L-strain | Asthma | 22 | .185 | .061 | .854 | .398 |
Control | 18 | .169 | .058 |
CCA – common carotid artery; R – right; L – left; SD – standard deviation.
The mean values of distensibility and strain of right and left brachial arteries were higher, whereas stiffness was lower in asthmatic children than in controls (Table 3).
Table 3.
Radiological measurements | Groups | n | Mean | S.D. | t | Sig. |
---|---|---|---|---|---|---|
Brachial artery R-distensibilty | Asthma | 22 | 9.522 | 4.030 | 4.209 | .000 |
Control | 18 | 5.370 | 2.055 | |||
Brachial artery R-strain | Asthma | 22 | .116 | .051 | 4.012 | .000 |
Control | 18 | .068 | .020 | |||
Brachial artery R-stiffness | Asthma | 22 | 5.128 | 2.395 | −2.841 | .007 |
Control | 18 | 7.428 | 2.723 | |||
Brachial artery L-distensibilty | Asthma | 22 | 9.556 | 3.275 | 4.046 | .000 |
Control | 18 | 5.845 | 2.318 | |||
Brachial artery L-strain | Asthma | 22 | .115 | .039 | 3.664 | .001 |
Control | 18 | .076 | .027 | |||
Brachial artery L-stiffness | Asthma | 22 | 4.758 | 1.656 | −3.093 | .004 |
Control | 18 | 6.785 | 2.474 |
R – right; L – left; SD – standard deviation.
In comparison with the healthy individuals, the right and left renal arteries means had higher distensibility and strain and lower stiffness in the asthmatic group (Table 4).
Table 4.
Radiological measurements | Groups | n | Mean | S.D. | t | Sig. |
---|---|---|---|---|---|---|
Renal artery R-distensibilty | Asthma | 22 | 7.470 | 1.953 | 3.397 | .002 |
Control | 18 | 4.979 | 2.681 | |||
Renal artery R-strain | Asthma | 22 | .092 | .030 | 3.087 | .004 |
Control | 18 | .063 | .028 | |||
Renal artery R-stiffness | Asthma | 22 | 6.231 | 3.284 | −2.158 | .037 |
Control | 18 | 8.358 | 2.860 | |||
Renal artery L-distensibilty | Asthma | 22 | 7.366 | 2.083 | 3.062 | .004 |
Control | 18 | 5.200 | 2.388 | |||
Renal artery L-strain | Asthma | 22 | .088 | .019 | 2.875 | .007 |
Control | 18 | .067 | .027 | |||
Renal artery L-stiffness | Asthma | 22 | 5.859 | 1.457 | −2.489 | .020 |
Control | 18 | 7.769 | 2.977 |
R – right; L – left; SD – standard deviation.
When the age factor was considered as covariates in ANCOVA analysis (Table 5), the right and left brachial artery distensibility and strain were approximately 2 times higher in the asthmatic group than in controls. Approximately one-quarter of the difference (22.2–28.5%) was due to asthma for both left and right arteries. The distensibility and strain of the right renal artery were higher, whereas right renal artery stiffness was lower in asthmatic children; 19.2% the differences in right renal artery distensibility and 15.7% of the differences in the right artery strain were due to asthma. A very small portion of the change in the right renal artery stiffness (7.9%) was associated with asthma; 26.4% of the differences in left renal artery distensibility and 23.4% of the differences in strain in the same artery were due to age, not associated with asthma. The results of the analyses that were not statistically significant are not included in the Table 5.
Table 5.
Radiological measurements | Variables | F | Sig. | Partial eta squared | R2 | Adj. R2 |
---|---|---|---|---|---|---|
Brachial artery R-distensibility | Age | 1.61 | .212 | .042 | ||
Groups | 6.67 | .014 | .153 | .322 | .285 | |
Brachial artery R-strain | Age | .87 | .358 | .023 | ||
Groups | 6.47 | .015 | .149 | . 284 | .245 | |
Brachial artery L-distensibility | Age | .34 | .565 | .009 | ||
Groups | 8.90 | .005 | .194 | .307 | .270 | |
Brachial artery L-strain | Age | .06 | .803 | .002 | ||
Groups | 8.10 | .007 | .180 | .267 | .222 | |
Renal artery R-distensibility | Age | .01 | .944 | .000 | ||
Groups | 7.45 | .010 | .168 | .233 | .192 | |
Renal artery R-strain | Age | .00 | .948 | .000 | ||
Groups | 6.15 | .018 | .142 | .201 | .157 | |
Renal artery R-stiffness | Age | .71 | .405 | .019 | ||
Groups | 5.06 | .030 | .120 | .126 | .079 | |
Renal artery L-distensibility | Age | 5.524 | .024 | .130 | ||
Groups | 1.821 | .185 | .047 | .302 | .264 | |
Renal artery L-strain | Age | 4.827 | .034 | .115 | ||
Groups | 1.566 | .219 | .041 | .273 | .234 |
Groups: Children with Asthma and normal children. R – right; L – left. No statistically significant variables were excluded from the table.
The multiple ANCOVA analysis revealed that approximately one-fifth of the change in left and right brachial arteries distensibility, strain and right renal artery distensibility, strain, and stiffness were associated with asthma. In contrast, left renal artery distensibility, strain, and stiffness were not associated with asthma.
Discussion
This study aimed to assess the elasticity properties of various arteries in children with asthma. On the basis of the association between chronic inflammation and atherosclerosis, we hypothesized that the impaired elasticity in children with asthma could increase the risk of atherosclerotic disease. For this purpose, left and right brachial arteries, left and right renal arteries, and left and right carotid arteries were assessed as markers of atherosclerosis. During the atherosclerotic process, increased arterial stiffness and decreased arterial distensibility and strain have been reported among adults [16]. Our results showed increased distensibility and strain in renal and brachial arterial structures, while stiffness was reduced. Carotid arteries measurements did not change. We believe that these results probably are due to the use of inhaled corticosteroids in these children with asthma. Therefore, it appears that inhaled corticosteroids may have a protective effect against atherosclerosis. In this study the results of multiple ANCOVA analysis showed that almost one-fifth of the changes in both left and right brachial arteries distensibility and strain and right renal artery distensibility, strain, and stiffness were associated with asthma.
There is little published data on the association between childhood-onset asthma and atherosclerosis and few studies have evaluated elasticity in asthmatic children. Using carotid-femoral pulse wave velocity measurements, Steinman et al. showed increased arterial stiffness in children with asthma [17]. Weiler et al. examined the arterial stiffness in peripheral large arteries and small arteries and found no difference between asthmatic adults and control subjects. These authors also reported a positive correlation between the small arterial elasticity index and forced expiratory volume at 1 second (FEV1) [18]. Brachial-ankle pulse wave velocity measurements were performed to assess the arterial stiffness in a study by Sun et al., where an increased arterial stiffness was found among adult asthmatic patients with stable disease as compared to the healthy controls. In that study, a negative correlation between brachial-ankle pulse wave velocity and FEV1 was found [19]. In a recent study by Ulger et al., a difference between asthmatic children and control subjects was found in terms of aortic stiffness parameters, and inhaled steroids were reported as a possible reason for decreasing aortic stiffness [16]. Ayer et al. suggested that the reduction in lung volume during the early childhood could be associated with increased arterial stiffness [20]. On the other hand, Bhatt et al. reported no significant difference between the markers of systemic inflammation and arterial stiffness in patients with chronic obstructive pulmonary disease [21].
In the current study we found that using inhaled corticosteroids may have protective effects against atherosclerosis. Many previous studies have also found a tendency toward decreased arterial stiffness with the use of inhaled corticosteroids/long-acting beta agonists, and there was a more marked decrease in stiffness in adult patients with higher arterial stiffness [21–23]. A proposed mechanism that may explain the decrease in arterial stiffness involves nitric oxide synthesis and vasodilation [24]. Otsuki et al. compared healthy controls with adult asthmatic patients receiving inhaled corticosteroids. They found decreased carotid atherosclerosis and concluded that the inhaled corticosteroids may provide protection against atherosclerosis [25]. Since inhaled corticosteroids exert a strong anti-inflammatory effect on airways, they are the most effective agents for long-term disease control [26]. On the other hand, corticosteroids also have some potential pro-atherogenic and metabolic effects, such as the induction or worsening of hypertension, hyperglycemia, hypercholesterolemia, and hypertriglyceridemia [27]. Clinicians must also be careful in prescribing steroids to patients who live in endemic areas. For instance, Alsharif et al. diagnosed a woman, who lived Mexico, with hyperinfection syndrome due to Strongyloides stercoralis, most probably exacerbated by prednisone given for asthma. Steroid was discontinued and she improved with treatment [28]. Due to such effects, it has been proposed that the use of corticosteroids may be associated with the development of atherosclerosis, although until now this connection has not been clearly established [29]. Also, since there is an increased risk of atherosclerosis in inflammatory conditions [30], it can be suggested that corticosteroids may somehow alleviate the atherosclerotic vascular diseases through their anti-inflammatory properties. A cohort study from the UK indicated that treatment with oral corticosteroids was associated with risk of myocardial infarction, whereas inhaled corticosteroids were not associated with increased risk of myocardial infarction in the general population [31]. On the other hand, another study showed inhaled corticosteroids were associated with decreased the risk of acute myocardial infarction in asthmatic patients [32]. These findings indicate that inhaled corticosteroids might have properties that protect against atherosclerosis, whereas oral corticosteroids might increase risk of atherosclerosis.
Several studies suggest the utility of aortic distensibility as a non-invasive method in the detection early atherosclerosis among adults. Mikola et al. studied the aorta and carotid arteries in children and found that aortic and carotid distensibility decreased with age and this decrease was more pronounced in boys than in girls [33]. Increased stiffness leads to decreased diastolic blood pressure and increased pulse pressure, causing increased left ventricular afterload and a wear-and-tear effect on the arterial wall tissue.
We failed to find any study evaluating renal, brachial, and carotid arteries distensibility, strain, and stiffness together in childhood-onset asthma patients; therefore, we were unable to compare our results with other studies in children.
Conclusions
We found decreased stiffness and increased distensibility and strain in some peripheral arteries in asthmatic children. The use of inhaled corticosteroids in this group of asthmatic children could have provided certain protective effects. We believe that inhaled corticosteroids may protect against atherosclerosis. Further studies with larger sample sizes are warranted to better elucidate the association of stiffness, distensibility, and strain in childhood asthma.
Footnotes
Source of support: Departmental sources
References
- 1.Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA) 2006. Available at: http://www.ginasthma.org/
- 2.Liu Z, Li P, Wang J, et al. A meta-analysis of IL-13 polymorphisms and pediatric asthma risk. Med Sci Monit. 2014;20:2617–23. doi: 10.12659/MSM.891017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Brewczyński PZ, Brodziak A. Have recent investigations into remission from childhood asthma helped in understanding the pathogenesis of this disease? Med Sci Monit. 2015;21:570–75. doi: 10.12659/MSM.893575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Wu TL, Chang PY, Tsao KC, et al. A panel of multiple markers associated with chronic systemic inflammation and the risk of atherogenesis is detectable in asthma and chronic obstructive pulmonary disease. J Clin Lab Anal. 2007;21:367–71. doi: 10.1002/jcla.20197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ramasamy R, Yan SF, Herold K, et al. Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis. Ann NY Acad Sci. 2008;1126:7–13. doi: 10.1196/annals.1433.056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol. 2009;6:399–409. doi: 10.1038/nrcardio.2009.55. [DOI] [PubMed] [Google Scholar]
- 7.Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:2045–51. doi: 10.1161/ATVBAHA.108.179705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol. 2008;103:398–406. doi: 10.1007/s00395-008-0733-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension. 2005;46:1118–22. doi: 10.1161/01.HYP.0000185463.27209.b0. [DOI] [PubMed] [Google Scholar]
- 10.Anderson TJ. Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk. Can J Cardiol. 2006;22(Suppl B):72B–80B. doi: 10.1016/s0828-282x(06)70990-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Cohn JN. Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision making. Am J Hypertens. 2001;14:258–63. doi: 10.1016/s0895-7061(01)02154-9. [DOI] [PubMed] [Google Scholar]
- 12.O’Rourke MF, Staessen JA, Vlachopoulos C, et al. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens. 2002;15:426–44. doi: 10.1016/s0895-7061(01)02319-6. [DOI] [PubMed] [Google Scholar]
- 13.Safar ME, Blacher J, Jankowski P. Arterial stiffness. pulse pressure and cardiovascular disease-is it possible to break the vicious circle. Atherosclerosis. 2011;218:263–71. doi: 10.1016/j.atherosclerosis.2011.04.039. [DOI] [PubMed] [Google Scholar]
- 14.Lacombe F, Dart A, Dewar E, et al. Arterial elastic properties in man: A comparison of echo-Doppler indices of aortic stiffness. Eur Heart J. 1992;13:1040–45. doi: 10.1093/oxfordjournals.eurheartj.a060311. [DOI] [PubMed] [Google Scholar]
- 15.Iannuzzi A, Licenziati MR, Acampora C, et al. Preclinical changes in the mechanical properties of abdominal aorta in obese children. Metabolism. 2004;53:1243–46. doi: 10.1016/j.metabol.2004.03.023. [DOI] [PubMed] [Google Scholar]
- 16.Ülger Z, Gülen F, Özyürek AR. Abdominal aortic stiffness as a marker of atherosclerosis in childhood-onset asthma: a case-control study. Cardiovasc J Afr. 2015;26:8–12. doi: 10.5830/CVJA-2014-046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Steinmann M, Abbas C, Singer F, et al. Arterial stiffness is increased in asthmatic children. Eur J Pediatr. 2015;174:519–23. doi: 10.1007/s00431-014-2423-2. [DOI] [PubMed] [Google Scholar]
- 18.Weiler Z, Zeldin Y, Magen E, et al. Pulmonary function correlates with arterial stiffness in asthmatic patients. Respir Med. 2010;104:197–203. doi: 10.1016/j.rmed.2009.09.004. [DOI] [PubMed] [Google Scholar]
- 19.Sun WX, Jin D, Li Y, Wang RT. Increased arterial stiffness in stable and severe asthma. Respir Med. 2014;108:57–62. doi: 10.1016/j.rmed.2013.10.021. [DOI] [PubMed] [Google Scholar]
- 20.Ayer JG, Belousova EG, Harmer JA, et al. Lung function is associated with arterial stiffness in children. PLoS One. 2011;6:e26303. doi: 10.1371/journal.pone.0026303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Bhatt SP, Cole AG, Wells JM, et al. Determinants of arterial stiffness in COPD. BMC Pulm Med. 2014;14:1. doi: 10.1186/1471-2466-14-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Dransfield MT, Cockcroft JR, Townsend RR, et al. Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD. Respir Med. 2011;105:1322–30. doi: 10.1016/j.rmed.2011.05.016. [DOI] [PubMed] [Google Scholar]
- 23.Sabit RBC, Allanby C, Cockcroft JR, Shale DJ. Arterial stiffness is reduced by combination inhaled corticosteroid/long acting beta-2 agonist therapy in patients with COPD. Thorax. 2007;62:A142. [Google Scholar]
- 24.Dawes M, Chowienczyk PJ, Ritter JM. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Circulation. 1997;95:2293–97. doi: 10.1161/01.cir.95.9.2293. [DOI] [PubMed] [Google Scholar]
- 25.Otsuki M, Miyatake A, Fujita K, et al. Reduced carotid atherosclerosis in asthmatic patients treated with inhaled corticosteroids. Eur Respir J. 2010;36:503–8. doi: 10.1183/09031936.00090009. [DOI] [PubMed] [Google Scholar]
- 26.Statement by the British Thoracic Society, the British Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King’s Fund Centre, the National Asthma Campaign, the Royal College of General Practitioners, the General Practitioners in Asthma Group, the British Association of Accident and Emergency Medicine and the British Paediatric Respiratory Group. Guidelines on the management of asthma. Thorax. 1993;48:S1–S24. doi: 10.1136/thx.48.2_suppl.s1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Nashel DJ. Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med. 1986;80:925–29. doi: 10.1016/0002-9343(86)90639-x. [DOI] [PubMed] [Google Scholar]
- 28.Alsharif A, Sodhi A, Murillo LC, et al. Wait!!! No Steroids for this Asthma…. Am J Case Rep. 2015;16:398–400. doi: 10.12659/AJCR.893729. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Moreland LW, O’Dell JR. Glucocorticoids and rheumatoid arthritis: back to the future? Arthritis Rheum. 2002;46:2553–63. doi: 10.1002/art.10567. [DOI] [PubMed] [Google Scholar]
- 30.Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999;340:115–26. doi: 10.1056/NEJM199901143400207. [DOI] [PubMed] [Google Scholar]
- 31.Varas-Lorenzo C, Rodriguez LA, Maguire A, et al. Use of oral corticosteroids and the risk of acute myocardial infarction. Atherosclerosis. 2007;192:376–83. doi: 10.1016/j.atherosclerosis.2006.05.019. [DOI] [PubMed] [Google Scholar]
- 32.Suissa S, Assimes T, Brassard P, Ernst P. Inhaled corticosteroid use in asthma and the prevention of myocardial infarction. Am J Med. 2003;115:377–81. doi: 10.1016/s0002-9343(03)00393-0. [DOI] [PubMed] [Google Scholar]
- 33.Mikola H, Pahkala K, Rönnemaa T, et al. Distensibility of the aorta and carotid artery and left ventricular mass from childhood to early adulthood. Hypertension. 2015;65:146–52. doi: 10.1161/HYPERTENSIONAHA.114.03316. [DOI] [PubMed] [Google Scholar]